| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 4179 | 2017 |
| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1736-1788, 2018 | 3824 | 2018 |
| Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 MG Griswold, N Fullman, C Hawley, N Arian, SRM Zimsen, HD Tymeson, ... The Lancet 392 (10152), 1015-1035, 2018 | 1894 | 2018 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and … JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ... The Lancet 392 (10159), 1923-1994, 2018 | 1654 | 2018 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The Lancet 396 (10258), 1223-1249, 2020 | 1574 | 2020 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 1317 | 2018 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 661 | 2018 |
| Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic … R Lozano, N Fullman, D Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 2091-2138, 2018 | 334 | 2018 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 274 | 2020 |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 236 | 2020 |
| The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017 A Etemadi, S Safiri, SG Sepanlou, K Ikuta, C Bisignano, R Shakeri, ... The lancet Gastroenterology & hepatology 5 (1), 42-54, 2020 | 232 | 2020 |
| Heat-not-burn tobacco product use in Japan: its prevalence, predictors and perceived symptoms from exposure to secondhand heat-not-burn tobacco aerosol T Tabuchi, S Gallus, T Shinozaki, T Nakaya, N Kunugita, B Colwell Tobacco control 27 (e1), e25-e33, 2018 | 210 | 2018 |
| Population health and regional variations of disease burden in Japan, 1990–2015: a systematic subnational analysis for the Global Burden of Disease Study 2015 S Nomura, H Sakamoto, S Glenn, Y Tsugawa, SK Abe, MM Rahman, ... The Lancet 390 (10101), 1521-1538, 2017 | 154 | 2017 |
| Awareness and use of electronic cigarettes and heat‐not‐burn tobacco products in Japan T Tabuchi, K Kiyohara, T Hoshino, K Bekki, Y Inaba, N Kunugita Addiction 111 (4), 706-713, 2016 | 139 | 2016 |
| Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 R Burstein, NJ Henry, ML Collison, LB Marczak, A Sligar, S Watson, ... Nature 574 (7778), 353-358, 2019 | 130 | 2019 |
| Heat-not-burn tobacco products: concerns from the Italian experience X Liu, A Lugo, L Spizzichino, T Tabuchi, R Pacifici, S Gallus Tobacco Control 28 (1), 113-114, 2019 | 116 | 2019 |
| Incidence of metachronous second primary cancers in Osaka, Japan: Update of analyses using population‐based cancer registry data T Tabuchi, Y Ito, A Ioka, I Miyashiro, H Tsukuma Cancer Science 103 (6), 1111-1120, 2012 | 95 | 2012 |
| Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic … MB Reitsma, PJ Kendrick, E Ababneh, C Abbafati, M Abbasi-Kangevari, ... The Lancet 397 (10292), 2337-2360, 2021 | 93 | 2021 |
| Tobacco smoking and the risk of subsequent primary cancer among cancer survivors: a retrospective cohort study T Tabuchi, Y Ito, A Ioka, T Nakayama, I Miyashiro, H Tsukuma Annals of oncology 24 (10), 2699-2704, 2013 | 82 | 2013 |
| Prevalence, use behaviors, and preferences among users of heated tobacco products: findings from the 2018 ITC Japan Survey E Sutanto, C Miller, DM Smith, RJ O’connor, ACK Quah, KM Cummings, ... International journal of environmental research and public health 16 (23), 4630, 2019 | 55 | 2019 |
Toshitaka MorishimaOsaka International Cancer Institute確認したメール アドレス: oici.jp
